Award recordCONTRACT

TEVA PHARMACEUTICALS USA, INC.

PIID VA797E17C0033· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $0 net obligations· UEI NEN9A34LRHJ5· PA

Description

INCORPORATE TEVA PHARMACEUTICALS USA, INC. SUBCONTRACTING PLAN.

Base award description: AWARD FOR FILGRASTIM SYRINGE BASE YEAR WITH FOUR ONE YEAR OPTIONS

First action · last action
2017-05-02 · 2022-01-05
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$32,546,606
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2017-05-02 · this action $0 · running total $0Modification P00002 · 2017-05-16 · this action $0 · running total $0Modification P00003 · 2018-01-23 · this action $0 · running total $0Modification P00004 · 2018-06-04 · this action $0 · running total $0Modification P00005 · 2019-01-09 · this action $0 · running total $0Modification P00006 · 2019-05-17 · this action $0 · running total $0Modification P00007 · 2020-01-06 · this action $0 · running total $0Modification P00008 · 2020-06-01 · this action $0 · running total $0Modification P00009 · 2020-12-15 · this action $0 · running total $0Modification P00010 · 2020-12-15 · this action $0 · running total $0Modification P00011 · 2021-05-25 · this action $0 · running total $0Modification P00012 · 2021-12-19 · this action $0 · running total $0Modification P00013 · 2022-01-05 · this action $0 · running total $0
  • Base2017-05-02+$0= $0
  • Mod P000022017-05-16+$0= $0
  • Mod P000032018-01-23+$0= $0
  • Mod P000042018-06-04+$0= $0
  • Mod P000052019-01-09+$0= $0
  • Mod P000062019-05-17+$0= $0
  • Mod P000072020-01-06+$0= $0
  • Mod P000082020-06-01+$0= $0
  • Mod P000092020-12-15+$0= $0
  • Mod P000102020-12-15+$0= $0
  • Mod P000112021-05-25+$0= $0
  • Mod P000122021-12-19+$0= $0
  • Mod P000132022-01-05+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-05-02+$0$0AWARD FOR FILGRASTIM SYRINGE BASE YEAR WITH FOUR ONE YEAR OPTIONS
Mod P00002· OTHER ADMINISTRATIVE ACTION2017-05-16+$0$0MOD TO CLARIFY THE PRODUCT NAME DESCRIPTION FOR FILGRASTIM
Mod P00003· ADD SUBCONTRACTING PLAN2018-01-23+$0$02018 SUBCONTRACTING PLAN
Mod P00004· EXERCISE AN OPTION2018-06-04+$0$0OPTION YEAR ONE TBO-FILGRASTIM SYRINGE
Mod P00005· ADD SUBCONTRACTING PLAN2019-01-09+$0$0TEVA 2019 SUBCONTRACTING PLAN
Mod P00006· EXERCISE AN OPTION2019-05-17+$0$0EXERCISE OPTION YEAR TWO
Mod P00007· ADD SUBCONTRACTING PLAN2020-01-06+$0$02020 SUBCONTRACTING PLAN
Mod P00008· EXERCISE AN OPTION2020-06-01+$0$0EXERCISE OPTION YEAR THREE
Mod P00009· OTHER ADMINISTRATIVE ACTION2020-12-15+$0$0TO INCORPORATE 2021 FEDERAL CEILING PRICES UNDER NATIONAL CONTRACT VA797E-17-C-0033.
Mod P00010· ADD SUBCONTRACTING PLAN2020-12-15+$0$0TO INCORPORATE 2021 SMALL BUSINESS SUBCONTRACTING PLAN UNDER NATIONAL CONTRACT VA797E-17-C-0033.
Mod P00011· EXERCISE AN OPTION2021-05-25+$0$0EXERCISE THE FOURTH AND FINAL OPTION YEAR FOR TBO-FILGRASTIM SYRINGES
Mod P00012· OTHER ADMINISTRATIVE ACTION2021-12-19+$0$0INCORPORATE 2022 FEDERAL CEILING PRICES UNDER NATIONAL CONTRACT VA797E-17-C-0033.
Mod P00013· ADD SUBCONTRACTING PLAN2022-01-05+$0$0INCORPORATE TEVA PHARMACEUTICALS USA, INC. SUBCONTRACTING PLAN.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NEN9A34LRHJ5)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0125NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79723D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79722D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
VA797E17A0007NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2018
V797D70217NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA797E17C0034NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797E17C0033_3600 · retrieved 2026-09-26.